Detalhe da pesquisa
1.
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.
Br J Cancer
; 123(10): 1490-1495, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32863385
2.
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06).
Gastric Cancer
; 21(3): 421-427, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28936560
3.
Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC06).
Gastric Cancer
; 21(3): 428, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29234896
4.
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.
Gastric Cancer
; 19(3): 927-38, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510663
5.
A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.
JAMA Oncol
; 10(1): 95-102, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38032680
6.
Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis.
Cancer Sci
; 104(6): 711-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23480814
7.
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402.
Acta Oncol
; 51(6): 768-73, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22283472
8.
Phase I study of topotecan and cisplatin in patients with small cell lung cancer.
Jpn J Clin Oncol
; 41(2): 197-203, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20937601
9.
[Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment].
Gan To Kagaku Ryoho
; 37(3): 439-42, 2010 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-20332679
10.
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial.
JAMA Oncol
; 6(12): 1931-1938, 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33057591
11.
Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung: Okayama Lung Cancer Study Group experience.
J Cancer Res Clin Oncol
; 135(1): 117-23, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18618142
12.
Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer.
Mol Cancer Ther
; 17(12): 2788-2795, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30275242
13.
Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).
Int J Radiat Oncol Biol Phys
; 69(3): 786-92, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17512126
14.
Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung.
Lung Cancer
; 58(1): 30-5, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17561305
15.
Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer.
J Cancer Res Clin Oncol
; 133(8): 519-24, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17370088
16.
A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer.
Cancer Chemother Pharmacol
; 60(1): 1-6, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17393168
17.
A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.
Cancer Chemother Pharmacol
; 60(1): 53-9, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17009034
18.
CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer.
Target Oncol
; 12(6): 787-794, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29064002
19.
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials.
Clin Colorectal Cancer
; 16(3): e171-e180, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856123
20.
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer.
Lung Cancer
; 53(2): 189-95, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16806573